Repligen (RGEN) Other Non-Current Assets (2011 - 2026)
Repligen (RGEN) posted quarterly Other Non-Current Assets of $4.0 million for Q2 2026, up 57.61% year-over-year from $2.6 million in Q2 2025, and down 31.17% quarter-over-quarter from $5.9 million in Q1 2026.
Repligen (RGEN) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Other Non-Current Assets for 16 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 57.61% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $4.0 million (up 57.61% YoY), while the FY2025 annual figure was $4.9 million, up 466.01% from the prior year.
- Other Non-Current Assets retreated to $4.0 million in Q2 2026 per RGEN's latest filing, from $5.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.9 million in Q1 2026 and bottomed at $631000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $2.0 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets slumped 48.2% — and 2025, when it soared 582.49%.
- Repligen's Other Non-Current Assets stood at $815000.0 in 2022, then soared by 56.69% to $1.3 million in 2023, then tumbled by 32.03% to $868000.0 in 2024, then soared by 466.01% to $4.9 million in 2025, then retreated by 17.59% to $4.0 million in 2026.
- Business Quant data shows RGEN's Other Non-Current Assets at $4.0 million in Q2 2026, $5.9 million in Q1 2026, and $4.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.05 Mn |
| Mar 31, 2026 | 5.88 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 868,000.00 |
| Sep 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 815,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 769,000.00 |
| Mar 31, 2022 | 631,000.00 |
| Dec 31, 2021 | 615,000.00 |
| Sep 30, 2021 | 620,000.00 |